These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF. Bruhn TO; Plotsky PM; Vale WW Endocrinology; 1984 Jan; 114(1):57-62. PubMed ID: 6317350 [TBL] [Abstract][Full Text] [Related]
24. [The development of immunoreactive corticotropin-releasing factor (IR-CRF) in the hypothalamus, pancreas and gastrointestinal tract of immature rats]. Ohtsuka K; Koshimizu T; Ohyama Y; Yokota Y Nihon Naibunpi Gakkai Zasshi; 1986 Jan; 62(1):34-44. PubMed ID: 3486137 [TBL] [Abstract][Full Text] [Related]
25. Characterization and modulation of corticotropin-releasing factor in the neurointermediate pituitary gland. Jeandel L; Van Dorsselaer A; Lutz-Bucher B; Koch B Neuroendocrinology; 1987 Feb; 45(2):146-51. PubMed ID: 3033535 [TBL] [Abstract][Full Text] [Related]
26. An improved methodology for the extraction and partial purification of porcine hypothalamic corticotrophin releasing factor. Bristow AF; Montague D; Synetos D; Jenkins G; Cockayne D; Schulster D J Endocrinol; 1980 Feb; 84(2):189-97. PubMed ID: 6245160 [TBL] [Abstract][Full Text] [Related]
27. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia. Engler D; Pham T; Fullerton MJ; Ooi G; Funder JW; Clarke IJ Neuroendocrinology; 1989 Apr; 49(4):367-81. PubMed ID: 2541360 [TBL] [Abstract][Full Text] [Related]
28. Effects of morphine on hypothalamic corticotropin-releasing factor (CRF), norepinephrine and dopamine in non-stressed and stressed rats. Suemaru S; Hashimoto K; Ota Z Acta Med Okayama; 1985 Dec; 39(6):463-70. PubMed ID: 3004111 [TBL] [Abstract][Full Text] [Related]
29. A different distribution of corticotropin releasing factor and arginine vasopressin contents in the hypothalamic nuclei after estrogen administration. Hashimoto K; Ohno N; Aoki Y; Kageyama J; Takahara J; Ofuji T Acta Med Okayama; 1981 Feb; 35(1):37-43. PubMed ID: 6266205 [TBL] [Abstract][Full Text] [Related]
30. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536 [TBL] [Abstract][Full Text] [Related]
31. Effects of ethanol on CRF release in vitro. Redei E; Branch BJ; Gholami S; Lin EY; Taylor AN Endocrinology; 1988 Dec; 123(6):2736-43. PubMed ID: 2848685 [TBL] [Abstract][Full Text] [Related]
32. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress. Hauger RL; Millan MA; Lorang M; Harwood JP; Aguilera G Endocrinology; 1988 Jul; 123(1):396-405. PubMed ID: 2838259 [TBL] [Abstract][Full Text] [Related]
33. Correlation between the stress-induced transient increase in corticotropin-releasing hormone content of the median eminence of the hypothalamus and adrenocorticotropic hormone secretion. Murakami K; Akana S; Dallman MF; Ganong WF Neuroendocrinology; 1989 Mar; 49(3):233-41. PubMed ID: 2541356 [TBL] [Abstract][Full Text] [Related]
34. [Sex difference in the circadian rhythm of corticotropin-releasing activity in the rat hypothalamus (author's transl)]. Honma S Hokkaido Igaku Zasshi; 1976 Jan; 51(1):23-39. PubMed ID: 1084854 [TBL] [Abstract][Full Text] [Related]
35. Immunological detection of pro-corticotropin releasing factor (CRF) in rat hypothalamus and pancreatic extracts. Evidence for in vitro conversion into CRF. Lauber M; Clavreul C; Vaudry H; Cohen P FEBS Lett; 1984 Jul; 173(1):222-6. PubMed ID: 6611275 [TBL] [Abstract][Full Text] [Related]
36. [Corticotropin-releasing activity of rat hypothalamic extracts under stress conditions]. Drzhevetskaia IA; Borodin AD Patol Fiziol Eksp Ter; 1971; 15(3):42-5. PubMed ID: 5315176 [No Abstract] [Full Text] [Related]
37. Evaluation of changes in the secretion of corticotrophin releasing activity using the isolated rat hypothalamus incubated in vitro. Kamstra GS; Thomas P; Sadow J J Endocrinol; 1983 May; 97(2):291-300. PubMed ID: 6602198 [TBL] [Abstract][Full Text] [Related]
38. Distribution and characterization of immunoreactive corticotropin-releasing factor in human tissues. Suda T; Tomori N; Tozawa F; Mouri T; Demura H; Shizume K J Clin Endocrinol Metab; 1984 Nov; 59(5):861-6. PubMed ID: 6332825 [TBL] [Abstract][Full Text] [Related]
39. Conditions for the reliable use of lesioned rats for the assay of CRF in tissue extracts. Witorsch RJ; Brodish A Endocrinology; 1972 Feb; 90(2):552-7. PubMed ID: 4333139 [No Abstract] [Full Text] [Related]
40. Subcellular distribution of corticotropin-releasing factor in the medio-basal hypothalamus of the rat. Briaud B; Enjalbert A; Mialhe C; Kordon C Neuroendocrinology; 1979; 28(6):371-6. PubMed ID: 313532 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]